Details for New Drug Application (NDA): 020374

✉ Email this page to a colleague

NDA 020374 describes INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, which is a drug marketed by Fresenius and is included in one NDA. Additional details are available on the INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER profile page.

The generic ingredient in INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.

Tradename:	INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Applicant:	Fresenius
Ingredient:	calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
Patents:	0

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;INTRAPERITONEAL			Strength	18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Approval Date:	Jun 13, 1994	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;INTRAPERITONEAL			Strength	18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Approval Date:	Jun 13, 1994	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;INTRAPERITONEAL			Strength	18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Approval Date:	Jun 13, 1994	TE:		RLD:	No

Complete Access Available with Subscription